Objectives: Antiphospholipid antibodies (aPLA) have been shown to enhance thrombus formation by increasing the expression of adhesive receptors on endothelial cells including P-selectin. The P-selectin counter-receptor on leukocytes is P-selectin glycoprotein ligand-1 (PSGL-1). We have previously described a variable number of tandem repeats (VNTR) polymorphism in the mucin-like region of PSGL-1, with three alleles: allele A 16 repeats; allele B 15 repeats; and allele C 14 repeats.
Methods: We compared the PSGL-1 VNTR allele and genotype frequencies in 90 antiphospholipid syndrome (APS) patients with thrombosis, 39 patients with persistent aPLA-positivity and without thrombosis, and 203 healthy controls.
Results: The frequency of the B allele was significantly higher in APS patients with thrombosis compared to patients without thrombosis (p=0.023). When we compared the groups by genotype frequencies, we found a markedly higher frequency of the AB genotype in APS patients with thrombosis than in aPL-positive patients without thrombosis (38.9% versus 10.3%, p=0.001) or in normal population (38.9% versus 22.2%, p=0.0048).
Conclusions: We suggest that the VNTR polymorphism of PSGL-1 is a significant determinant of the thrombotic predisposition of patients with APS. Further, risk appears to correlate best with the combination of alleles inherited rather than the presence of any particular allele.
- PSGL-1 VNTR polymorphism
- antiphospholipid syndrome
- p-selectin glycoprotein ligand-1
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.